off-patent

Paul Wicks , a co-author of the paper, said social network-run studies may be most useful for testing efficacy of so-called off-label or off-patent compounds that patients are using but are unlikely to ever attract pharmaceutical company interest.

ALS Study Shows Social Media's Value as Research Tool Amy Dockser Marcus 2011

The investigators will conduct clinical trials of new regimens involving the use of already licensed, off-patent antimicrobial therapies to reduce the risk of antimicrobial resistance developing in the diseases of interest.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics NIH/NIAID 2010

However, as the number of products going off-patent slows beyond 2015, the attractiveness of the U.S. generics business could dim.

Sun Pharma Bets on Emerging Markets Rumman Ahmed 2011

Over the last decade, most of the industry has been slashing research and development in favor of M&A and megadeals; many of the blockbusters coming off-patent were created by companies that no longer exist.

'The Biomedical Century' Joseph Rago 2011

One stumbling block is that some compounds are already off-patent, diminishing the financial incentive for a company to pursue it.

Researchers Show Gains in Finding Reusable Drugs Amy Dockser Marcus 2011

Strides Arcolab has a pact to supply Pfizer with off-patent injectable cancer drugs for sale in the U.S.

Strides Arcolab to Launch Cancer Treatment Injection in U.S. Rumman Ahmed 2011

In an interview, Mr. White said Abbott has been studying a split for the past few years, and structured certain acquisitions and created a unit to sell old, off-patent medicines with an eye toward a potential division.

Abbott to Split Into Two Companies Jonathan D. Rockoff 2011

The investigators will conduct clinical trials of new regimens involving the use of already licensed, off-patent antimicrobial therapies to reduce the risk of antimicrobial resistance developing in the diseases of interest.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics The Huffington Post News Team 2010

Getty Images Most sterile injectables have been off-patent for decades, but unlike other cheap generic drugs with low profit margins, production is complex and requires special facilities.

The Bush-Obama Rx Shortages 2011

Meanwhile, the saturated domestic market faces a major shake-up as the Japanese government pushes for increased use of generic drugs and implements bigger price cuts to off-patent drugs.

Astellas Pharma Eyes Unmet Medical Needs Kana Inagaki 2011